Sep 06 2024 This Week in Cardiology

Sep 06 2024 This Week in Cardiology

Feedback on ABYSS and beta-blockers, more ESC recap, including SHAM-PVI, FINEARTS-HF, and RESHAPE HF2 trials are the topics John Mandrola, MD, discusses in today's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I. Feedback on ABYSS

Setbacks After Stopping Beta-Blockers

https://www.medscape.com/viewarticle/setbacks-after-stopping-beta-blockers-2024a1000fv7

Beta-Blockers Post-MI? No for Me, Even After the ABYSS Trial

https://www.medscape.com/viewarticle/beta-blockers-post-mi-no-me-even-after-abyss-trial-2024a1000fva

  • ABYSS trial https://www.nejm.org/doi/full/10.1056/NEJMoa2404204
  • REDUCE AMI https://www.nejm.org/doi/full/10.1056/NEJMoa2401479
  • QOL paper REDUCE AMI https://doi.org/10.1093/ehjcvp/pvae062
  • Atenolol ED paper 10.1016/j.ehj.2003.08.016

II. SHAM-PVI

  • JAMA SHAM-PVI paper https://jamanetwork.com/journals/jama/article-abstract/2823283
  • Gupta QOL paper https://pubmed.ncbi.nlm.nih.gov/33952593/

III. FINEARTS HF

Finerenone Benefits Heart Failure With Preserved EF

https://www.medscape.com/viewarticle/finerenone-benefits-heart-failure-preserved-ef-2024a1000fza

Topline Finerenone Results Point to Advance in Heart Failure

https://www.medscape.com/viewarticle/topline-finerenone-results-point-advance-heart-failure-2024a1000fq2

  • FINEHEARTS -HF NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2407107
  • FIDELIO-DKD https://www.nejm.org/doi/full/10.1056/NEJMoa2025845
  • FIGARO-DKD https://www.nejm.org/doi/full/10.1056/NEJMoa2110956
  • Why Have We Not Been Able to Demonstrate Reduced Mortality in Patients With HFmrEF/HFpEF? https://doi.org/10.1016/j.jacc.2024.08.033

IV. RESHAPE HF

TEER in Functional MR: Data Deluge, but No Easy Answers

https://www.medscape.com/viewarticle/teer-functional-mr-data-deluge-no-easy-answers-2024a1000fvg

  • Mitra FR https://www.nejm.org/doi/full/10.1056/NEJMoa1805374
  • COAPT https://www.nejm.org/doi/full/10.1056/NEJMoa1806640
  • RESHAPE- HF2 https://www.nejm.org/doi/full/10.1056/NEJMoa2314328
  • RESHAPE Subgroup paper https://doi.org/10.1016/j.jacc.2024.08.027

You may also like:

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Episoder(402)

Feb 27 2026 This Week in Cardiology

Feb 27 2026 This Week in Cardiology

A superb note on CPR and DNR orders, patients' vs doctors' preferences for statins, more on GLP-1s, another LAAC story, and some closing cautionary notes on PFA are the topics John Mandrola, MD, discu...

27 Feb 29min

Feb 20 2026 This Week in Cardiology

Feb 20 2026 This Week in Cardiology

EVOLUT Low Risk data, a provocative meta-analysis, DNR orders, targeted hypothermia, good news in HFpEF evidence, and GLP-1s as AF drugs are the topics John Mandrola, MD, discusses in this week's podc...

20 Feb 25min

Feb 13 2026 This Week in Cardiology

Feb 13 2026 This Week in Cardiology

Ticagrelor vs prasugrel, a new LAAC device, pulsed field ablation AF results, lifestyle intervention in AF, the term "provider" vs "doctor," and coffee are the topics John Mandrola, MD, discusses in t...

13 Feb 29min

Feb 06 2026 This Week in Cardiology

Feb 06 2026 This Week in Cardiology

Problems with the PREVENT score, a breakthrough in lipid-lowering therapy, a surprising benefit in stroke care, and more thoughts on statins and preventive care of heart disease are the topics John Ma...

6 Feb 23min

Jan 30 2026 This Week in Cardiology

Jan 30 2026 This Week in Cardiology

Listener feedback, huge news in the rapidly expanding world of PFA AF Ablation, obesity, and a beautiful trial studying an AI-enhanced diagnostic tool in the office are the topics discussed by John Ma...

30 Jan 27min

Jan 23 2026 This Week in Cardiology

Jan 23 2026 This Week in Cardiology

Listener feedback, the value of procedural volume for TAVR and MTEER, ventricular arrhythmia in older athletes, and the Goldilocks time horizon for predicting and modifying CV risk are the topics John...

23 Jan 29min

Jan 16, 2026 This Week in Cardiology

Jan 16, 2026 This Week in Cardiology

Some great listener feedback, one of the best studies of the year in atrial fibrillation and heart failure, imaging to exclude left atrial thrombus, and a truly amazing first cardiac procedure are the...

16 Jan 30min

Jan 09 2026 This Week in Cardiology

Jan 09 2026 This Week in Cardiology

The limits of knowing coronary artery disease anatomy, fish oil and AF risk, a new drug for PSVT, and maybe I was wrong about a drug for AF conversion (the RAFF4 trial). These are the topics John Mand...

9 Jan 28min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
jss
rekommandert
forskningno
sinnsyn
tomprat-med-gunnar-tjomlid
villmarksliv
rss-paradigmepodden
rss-nysgjerrige-norge
liberal-halvtime
nevropodden
fjellsportpodden
kvinnehelsepodden
diagnose
tidlose-historier
rss-inn-til-kjernen-med-sunniva-rose
psykopoden
nordnorsk-historie
rss-hoyt-lavt-med-ida-tonseth